Video Experimental Relacionado

Updated: Apr 11, 2026

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

Avanzar en la comprensión biológica y el descubrimiento terapéutico con sondas de pequeñas moléculas

Stuart L Schreiber¹, Joanne D Kotz², Min Li³

¹Probe Development Center, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA; Howard Hughes Medical Institute, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Center for the Science of Therapeutics, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.

|June 6, 2015

Resumen

Las sondas de pequeñas moléculas, cruciales para comprender la biología y las enfermedades, ahora son más accesibles gracias al Programa de Bibliotecas Moleculares de los NIH. Estas herramientas químicas permiten nuevas vías de investigación y descubrimiento de fármacos, destacando la necesidad de innovación continua.

Área de la Ciencia:

Biología Química Biología química.
Descubrimiento de Drogas Descubrimiento de Drogas
Las sondas moleculares.

Sus antecedentes:

Las sondas de pequeñas moléculas son vitales para la investigación biológica y la evaluación de objetivos terapéuticos.
Históricamente, la falta de sondas disponibles limitó su uso generalizado en la investigación de vías biológicas y enfermedades.
Los Institutos Nacionales de la Salud (NIH) iniciaron el Programa de Bibliotecas Moleculares en 2005 para abordar esta brecha.

Objetivo del estudio:

Describir cómo las nuevas sondas de pequeñas moléculas, desarrolladas a través del Programa de Bibliotecas Moleculares de los NIH, facilitan la exploración biológica.
Para ilustrar el papel de estas sondas en la prueba de nuevas hipótesis terapéuticas.
Destacar el impacto de las sondas de pequeñas moléculas en la investigación biológica y el desarrollo de medicamentos.

Principales métodos:

El estudio es una pieza de perspectiva, que analiza el impacto del Programa de Bibliotecas Moleculares de los NIH.
Se centra en la identificación y aplicación de nuevas sondas de pequeñas moléculas.
El análisis se basa en experiencias habilitadas por las innovaciones del programa.

Principales resultados:

Se han puesto a disposición nuevas sondas de pequeñas moléculas para una gama más amplia de objetivos y vías biológicas.
Estas sondas permiten la exploración de procesos biológicos e hipótesis terapéuticas previamente no probadas.
El programa ha ampliado el acceso y la innovación en la ciencia de las pequeñas moléculas.

Conclusiones:

Las sondas de moléculas pequeñas son herramientas poderosas para avanzar en el entendimiento biológico e identificar medicamentos potenciales.
La disponibilidad de estas sondas cierra la brecha entre la investigación fundamental y el desarrollo terapéutico.
La innovación continua en la ciencia del descubrimiento terapéutico es esencial.

Más Videos Relacionados

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Videos de Conceptos Relacionados

Labeling DNA Probes

Labeling DNA Probes

DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

In-situ Hybridization

In-situ Hybridization

In situ hybridization (ISH) is a technique used to detect and localize specific DNA or RNA molecules in cells, tissue, or tissue sections using a labeled probe. The technique was first used in 1969 for the investigation of nucleic acids. It is currently an essential tool in scientific research and clinical settings, especially for diagnostic purposes.
Types of probes and labels
A probe is a complementary strand of DNA or RNA that binds to corresponding nucleotide sequences in a cell. Many...

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...